medigraphic.com
Coordinación General de Investigación de la Facultad de Salud Pública y Nutrición y la Dirección General de Sistemas e Informática de la Universidad Autónoma de Nuevo León

2006, Number 2

<< Back

Rev Salud Publica Nutr 2006; 7 (2)

Formas farmacéuticas y su administración ¿cuales no deben partirse o triturarse?

Gracia VSL, Camacho MIA, León RL, Chávez M

Language: Spanish
References: 73
Page:
PDF size: 358.35 Kb.


ABSTRACT

When a patient goes to a pharmacy and presents/displays a prescription receives in exchange for this one active principles that appear in different pharmaceutical forms. The elaboration of the pharmaceutical forms is of extreme importance to guarantee a rational use of the active principles adapting them to the route of appropriate administration. Most of medicines used actually they are in solid form, reason why the practice to crush tablets is common and to mix them with foods before administering them, especially in institutional establishments of medical attention. Generally, any tablet that is covered is in support it of a reason and it does not have to be crushed. The formulations with enteric cover or of liberation never prolonged must be crushed because they can cause irritation digestive and generate indirect effect or toxicity.


REFERENCES

  1. Aiache, J.M., S. Aiache and R. Renoux. 1996. Introducción al estudio del medicamento. 1º Edición. Editorial MASSON, España

  3. Secretaría de Salud 2002. Ley General de Salud. Tomo 1 y 2 Ed. Porrua.

  5. Aiache, J.M., et. al., Op. cit.

  7. Idem.

  9. Secretaria de Salud 2000. Farmacopea de los Estados Unidos Mexicanos. SSA/Comisión Permanente de la FEUM. 7a. Ed. México.

  11. Mobley, C. 2003. Anatomical and physiological considerations for pharmacy compounding. Drug Topics. 64-72

  13. Aiache, J.M., et. al. , Op. cit.

  15. Mobley, C., Op. cit

  17. Bruning, W.C. and J. Jr. Setaro. 1983. Oral solid dosage forms: be sure before you crush them. Pharmacy Times. pp 28-30

  19. Porter, S.C. 2000. Coating of Pharmaceutical Dosage Forms en Remington: The Science and Practice of Pharmacy 20th edition Lippincott Williams & Wilkins

  21. Stanford University/School of Medicine 2002 Pill-splitting can yield cost savings on common prescription drugs, Stanford researchers find (http://mednews.stanford.edu/releases/2002/august/pillsplitting.html)

  23. Marriott, J.L. and R.L.. Nation. 2002. Splitting tablets. Aust Prescr. 25: 133-135

  25. Bruning, W.C. and J. Jr. Setaro, Op. cit.

  27. Mitchell, J.F., 1996. Oral dosage forms that should not be crushed. Hospital Pharmacy. 31: 27-37

  29. Mitchell, J.F., 2000. Oral dosage forms that should not be crushed: 2000 updated, Hospital Pharmacy. 35 (Suppl 5): 553-557

  31. Lacy, Ch. F., L. L. Armstrong, M. P. Goldman 2000. Drug Information Handbook: Pocket, 2000-2001 Lexi-Comp, Inc.; 5th edition (June 15, 2000); 1213 pages

  33. Drugs that should not be crushed. 1999. RN; 62 (Suppl 8): 24ac2-24ac4

  35. Bachynsky, J., Ch. Wiens and K. Melnychuk. 2002. The practice of splitting tablets cost and therapeutic aspects. Pharmacoeconomics. 20 (Suppl 5): 339-346

  37. Wordell, D.C. 1988. Should you crush that tablet. Nursing. 1: 48-49

  39. Melgoza, L.M., L. Contreras, S. Rodríguez y M. González. 2002. Sistemas matriciales de liberación controlada. Revista Mexicana de Ciencias Farmacéuticas. 33 (Supl 4): 58-66

  41. Díaz, J.J., A.R. López. 2002. Excipientes de liberación prolongada para la vía oral. Informacéutico. pp23-29

  43. Miller, D., H. Miller. 2000. To crush or not to crush? Nursing. 30 (Suppl 2): 51-54

  45. Stuart, M. 2003. To crush or not to crush? General Practitioner. 82

  47. David, U. and E. Etchells. 2005. Avoid the crush: hazards of medication administration in patients with dysphagia or a feeding tube. CMAJ. 172 (Suppl 7): 871-872

  49. Porter, S.C.. Op. cit.

  51. Diccionario de Especialidades Farmacéuticas PLM.2004 50 ed. Ediciones PLM, México

  53. Marriott, J.L. and R.L.. Nation, Op. cit

  55. Bachynsky, J., et. al, Op. cit

  57. Winckler, J.D. 2004. Tablet splitting appropriateness for patients. J. Am Pharm Assoc. 44 (Suppl 3): 324-325.

  59. Schellhase, E. and K. Hardin. 2003. Development and implementation of a tablet splitting education program in a veterans affairs medical center. Hospital Pharmacy. 38 (Suppl 5): 453-457

  61. Cohen, R.M. and N.M Davis. 1994. Improperly crushing oral dosage forms. American Pharmacy. 34(Suppl 9): 21

  63. Sedrati, M., P. Arnaud, E. J Montan and F. Brion. 1994. Splitting tablets in half. Am J Hosp Pharm. 51: 548-552

  65. Fischbach, M. S., J. Gold, M. Lee, J. Jergal, G. Litner and P. Rochon. 2001. Pill-splitting in a long-term care facility. CMAJ. 164 (Suppl 6): 785-786

  67. Carr-Lopez, S., M. Mallet and T. Morse. 1995. The tablet splitter: barrier to compliance or cost-saving instrument? AJHSP. 52 (Suppl 23): 2707-2708

  69. Peek B. and A. Al-Achi. 2002. Accuracy of tablet splitting by elderly patients. JAMA..288 (Suppl 4): 451-452

  71. Farell, N.C., T. Cookson and S. Scanton. 1999. Relationship between tablet splitting and compliance, drug acquisition cost, and patient acceptance. AJHSP. 56 (Suppl 24): 2542-2545

  73. Stanford University/School of Medicine, Op. cit.




2020     |     www.medigraphic.com